Proffitt & Goodson’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-87
Closed -$4K 244
2021
Q2
$4K Sell
87
-5
-5% -$234 ﹤0.01% 240
2021
Q1
$4K Hold
92
﹤0.01% 233
2020
Q4
$3K Buy
92
+7
+8% +$197 ﹤0.01% 229
2020
Q3
$1K Hold
85
﹤0.01% 262
2020
Q2
$1K Hold
85
﹤0.01% 274
2020
Q1
$1K Hold
85
﹤0.01% 211
2019
Q4
$2K Hold
85
﹤0.01% 203
2019
Q3
$2K Hold
85
﹤0.01% 194
2019
Q2
$2K Hold
85
﹤0.01% 188
2019
Q1
$1K Hold
85
﹤0.01% 199
2018
Q4
$1K Hold
85
﹤0.01% 170
2018
Q3
$3K Buy
+85
New +$3.83K ﹤0.01% 126

Other funds holding ADNT

Proffitt & Goodson's ADNT Position: Q3 2021 in Review

Proffitt & Goodson sold out of Adient (ADNT) in Q3 2021, closing a stake of 87 shares — an estimated $4K sold.

Proffitt & Goodson first reported a position in ADNT in Q3 2018 and held it in 12 quarters. The position peaked at $4K in Q2 2021. 270 funds tracked by Wall St. Rank hold ADNT as of Q3 2021.

  • Proffitt & Goodson reported no remaining Adient position as of Q3 2021 after selling out during the quarter.
  • Proffitt & Goodson sold 87 Adient shares in Q3 2021, an estimated $4K.
  • Proffitt & Goodson first reported a position in Adient in Q3 2018 and held it in 12 quarters.
  • Proffitt & Goodson's Adient position peaked at $4K in Q2 2021.
  • 270 funds tracked by Wall St. Rank held Adient as of Q3 2021.

Based on Proffitt & Goodson's 13F filing for Q3 2021, filed 1 Nov 2021.